IE
EMMA

Israel Englander’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Israel Englander’s Portfolio EMMA Stock Details EMMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,515
Closed -$80K – 4247
2017
Q3 		$80K Buy
+3,515
New +$81.8K ﹤0.01% 3378

Other funds holding EMMA

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.78B AUM 23.76% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

Israel Englander's EMMA Position: Q4 2017 in Review

Israel Englander sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q4 2017, closing a stake of 3,515 shares — an estimated $80K sold.

Israel Englander first reported a position in EMMA in Q3 2017 and held it in 1 quarter. The position peaked at $80K in Q3 2017. 7 funds tracked by Wall St. Rank hold EMMA as of Q4 2017.

  • Israel Englander reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Israel Englander sold 3,515 Emmaus Life Sciences, Inc. Common Stock shares in Q4 2017, an estimated $80K.
  • Israel Englander first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Israel Englander's Emmaus Life Sciences, Inc. Common Stock position peaked at $80K in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q4 2017.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.